Phase 4 Osteoarthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been experiencing pain or symptoms in one knee for more than 6 months, diagnosed as knee osteoarthritis according to standard medical guidelines
- Your knee osteoarthritis has been graded as mild to moderate (Grade 1 to 3) on a standard X-ray scoring system
- Your knee pain during activity rates higher than 4 but lower than 8 out of 10 on a pain scale
Who may not be able to join:
- You have painful osteoarthritis in both knees at the same time
- Your knee osteoarthritis is severe (Grade 4 on the standard X-ray scoring system)
- Your osteoarthritis only affects the kneecap area of the joint, not the main part of the knee
- You have received a cortisone (steroid) injection into the knee in the past 3 months, or you regularly take steroid tablets by mouth
- You have received a hyaluronic acid injection into the knee in the past 12 months
- You have received a platelet-rich plasma (PRP) injection into the knee in the past 12 months
- You have another condition affecting the knee joint, such as a inflammatory disease, a history of joint infection, or bone damage (confirm with trial site)
- There are signs or suspicion of an active infection near or in the knee
- There are signs or suspicion of a tumour or cancer spread near the knee
- You have had a serious knee injury in the last 3 months
- You have significant memory or thinking difficulties, or difficulty understanding the study language well enough to complete questionnaires
- You have another serious health condition that could prevent you from participating or that makes cortisone injections unsafe for you (confirm with trial site)
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dien Hung Luong, MD, Centre hospitalier de l'Université de Montréal (CHUM)
Phone: 5148908000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
WOMAC Function
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.